RTI International: Changes in Federal Regulations Due to COVID-19 Pandemic Show Positive Response to Outpatient Dispensing of Medication for Opioid Use Disorder
December 16, 2020
December 16, 2020
RESEARCH TRIANGLE PARK, North Carolina, Dec. 16 (TNSJou) -- RTI International issued the following news on Dec. 15:
Researchers at RTI International (RTI), a nonprofit research institute, and the Texas State Board of Pharmacy, released a paper today in the Journal of American Medical Association (JAMA) discussing the changes in outpatient buprenorphine dispensing--a medication used to treat opioid use disorder--during the onset of the COVID-19 pandemic. The research showed that whil . . .
Researchers at RTI International (RTI), a nonprofit research institute, and the Texas State Board of Pharmacy, released a paper today in the Journal of American Medical Association (JAMA) discussing the changes in outpatient buprenorphine dispensing--a medication used to treat opioid use disorder--during the onset of the COVID-19 pandemic. The research showed that whil . . .